{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T23:32:53Z","timestamp":1759447973291},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T00:00:00Z","timestamp":1450310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s10067-015-3143-3","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T02:53:20Z","timestamp":1450320800000},"page":"213-218","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The association between serious infection and disease outcome in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"35","author":[{"given":"Mikiko","family":"Iguchi-Hashimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motomu","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritoshi","family":"Furu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikashi","family":"Terao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Ohmura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneyo","family":"Mimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,17]]},"reference":[{"issue":"9","key":"3143_CR1","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/art.10529","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O\u2019Fallon WM, Gabriel SE (2002) Predictors of infection in rheumatoid arthritis. Arthritis and rheumatism 46(9):2294\u20132300. doi: 10.1002\/art.10529","journal-title":"Arthritis and rheumatism"},{"issue":"22","key":"3143_CR2","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","volume":"343","author":"PE Lipsky","year":"2000","unstructured":"Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Engl J Med 343(22):1594\u20131602. doi: 10.1056\/nejm200011303432202","journal-title":"N Engl J Med"},{"issue":"12","key":"3143_CR3","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1002\/art.23141","volume":"56","author":"D Heijde van der","year":"2007","unstructured":"van der Heijde D, Klareskog L, Landewe R, Bruyn GA, Cantagrel A, Durez P, Herrero-Beaumont G, Molad Y, Codreanu C, Valentini G, Zahora R, Pedersen R, MacPeek D, Wajdula J, Fatenejad S (2007) Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis and rheumatism 56(12):3928\u20133939. doi: 10.1002\/art.23141","journal-title":"Arthritis and rheumatism"},{"issue":"2","key":"3143_CR4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.autrev.2012.06.008","volume":"12","author":"F Atzeni","year":"2012","unstructured":"Atzeni F, Sarzi-Puttini P, Botsios C, Carletto A, Cipriani P, Favalli EG, Frati E, Foschi V, Gasparini S, Giardina A, Gremese E, Iannone F, Sebastiani M, Ziglioli T, Biasi D, Ferri C, Galeazzi M, Gerli R, Giacomelli R, Gorla R, Govoni M, Lapadula G, Marchesoni A, Salaffi F, Punzi L, Triolo G, Ferraccioli G (2012) Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry. Autoimmun Rev 12(2):225\u2013229. doi: 10.1016\/j.autrev.2012.06.008","journal-title":"Autoimmun Rev"},{"issue":"7","key":"3143_CR5","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3899\/jrheum.101009","volume":"38","author":"Y Komano","year":"2011","unstructured":"Komano Y, Tanaka M, Nanki T, Koike R, Sakai R, Kameda H, Nakajima A, Saito K, Takeno M, Atsumi T, Tohma S, Ito S, Tamura N, Fujii T, Sawada T, Ida H, Hashiramoto A, Koike T, Ishigatsubo Y, Eguchi K, Tanaka Y, Takeuchi T, Miyasaka N, Harigai M (2011) Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety. J Rheumatol 38(7):1258\u20131264. doi: 10.3899\/jrheum.101009","journal-title":"J Rheumatol"},{"issue":"11","key":"3143_CR6","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1002\/art.21386","volume":"52","author":"J Listing","year":"2005","unstructured":"Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, Gromnica-Ihle E, Antoni C, Herzer P, Kekow J, Schneider M, Zink A (2005) Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis and rheumatism 52(11):3403\u20133412. doi: 10.1002\/art.21386","journal-title":"Arthritis and rheumatism"},{"issue":"8","key":"3143_CR7","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/acr.21666","volume":"64","author":"R Sakai","year":"2012","unstructured":"Sakai R, Komano Y, Tanaka M, Nanki T, Koike R, Nagasawa H, Amano K, Nakajima A, Atsumi T, Koike T, Ihata A, Ishigatsubo Y, Saito K, Tanaka Y, Ito S, Sumida T, Tohma S, Tamura N, Fujii T, Sugihara T, Kawakami A, Hagino N, Ueki Y, Hashiramoto A, Nagasaka K, Miyasaka N, Harigai M (2012) Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 64(8):1125\u20131134. doi: 10.1002\/acr.21666","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"3143_CR8","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/ard.2006.062760","volume":"66","author":"J Askling","year":"2007","unstructured":"Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, Coster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapaa-Dahlqvist S, Saxne T, van Vollenhoven RF, Klareskog L (2007) Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists. Ann Rheum Dis 66(10):1339\u20131344. doi: 10.1136\/ard.2006.062760","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"3143_CR9","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1002\/art.34530","volume":"64","author":"CS Crowson","year":"2012","unstructured":"Crowson CS, Hoganson DD, Fitz-Gibbon PD, Matteson EL (2012) Development and validation of a risk score for serious infection in patients with rheumatoid arthritis. Arthritis and rheumatism 64(9):2847\u20132855. doi: 10.1002\/art.34530","journal-title":"Arthritis and rheumatism"},{"issue":"8","key":"3143_CR10","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/ard.2010.146365","volume":"70","author":"JR Curtis","year":"2011","unstructured":"Curtis JR, Xie F, Chen L, Baddley JW, Beukelman T, Saag KG, Spettell C, McMahan RM, Fernandes J, Winthrop K, Delzell E (2011) The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents. Ann Rheum Dis 70(8):1401\u20131406. doi: 10.1136\/ard.2010.146365","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3143_CR11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/acr.21812","volume":"65","author":"J Widdifield","year":"2013","unstructured":"Widdifield J, Bernatsky S, Paterson JM, Gunraj N, Thorne JC, Pope J, Cividino A, Bombardier C (2013) Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care Res (Hoboken) 65(3):353\u2013361. doi: 10.1002\/acr.21812","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"3143_CR12","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1002\/art.27555","volume":"62","author":"JE Gottenberg","year":"2010","unstructured":"Gottenberg JE, Ravaud P, Bardin T, Cacoub P, Cantagrel A, Combe B, Dougados M, Flipo RM, Godeau B, Guillevin L, Le Loet X, Hachulla E, Schaeverbeke T, Sibilia J, Baron G, Mariette X (2010) Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthritis and rheumatism 62(9):2625\u20132632. doi: 10.1002\/art.27555","journal-title":"Arthritis and rheumatism"},{"issue":"2","key":"3143_CR13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.2008.089276","volume":"69","author":"JD Greenberg","year":"2010","unstructured":"Greenberg JD, Reed G, Kremer JM, Tindall E, Kavanaugh A, Zheng C, Bishai W, Hochberg MC (2010) Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. Ann Rheum Dis 69(2):380\u2013386. doi: 10.1136\/ard.2008.089276","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3143_CR14","doi-asserted-by":"crossref","first-page":"e59341","DOI":"10.1371\/journal.pone.0059341","volume":"8","author":"C Terao","year":"2013","unstructured":"Terao C, Hashimoto M, Yamamoto K, Murakami K, Ohmura K, Nakashima R, Yamakawa N, Yoshifuji H, Yukawa N, Kawabata D, Usui T, Yoshitomi H, Furu M, Yamada R, Matsuda F, Ito H, Fujii T, Mimori T (2013) Three groups in the 28 joints for rheumatoid arthritis synovitis\u2014analysis using more than 17,000 assessments in the KURAMA database. PLoS One 8(3):e59341. doi: 10.1371\/journal.pone.0059341","journal-title":"PLoS One"},{"issue":"4","key":"3143_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/03009742.2013.869831","volume":"43","author":"M Furu","year":"2014","unstructured":"Furu M, Hashimoto M, Ito H, Fujii T, Terao C, Yamakawa N, Yoshitomi H, Ogino H, Ishikawa M, Matsuda S, Mimori T (2014) Discordance and accordance between patient\u2019s and physician\u2019s assessments in rheumatoid arthritis. Scand J Rheumatol 43(4):291\u2013295. doi: 10.3109\/03009742.2013.869831","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"3143_CR16","doi-asserted-by":"crossref","first-page":"e98202","DOI":"10.1371\/journal.pone.0098202","volume":"9","author":"M Hashimoto","year":"2014","unstructured":"Hashimoto M, Fujii T, Hamaguchi M, Furu M, Ito H, Terao C, Yamamoto K, Yamamoto W, Matsuo T, Mori M, Ohmura K, Kawabata H, Mimori T (2014) Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis. PLoS One 9(5):e98202. doi: 10.1371\/journal.pone.0098202","journal-title":"PLoS One"},{"issue":"6","key":"3143_CR17","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/ard.2010.144741","volume":"70","author":"WG Dixon","year":"2011","unstructured":"Dixon WG, Kezouh A, Bernatsky S, Suissa S (2011) The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case\u2013control study. Ann Rheum Dis 70(6):956\u2013960. doi: 10.1136\/ard.2010.144741","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3143_CR18","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/annrheumdis-2011-200702","volume":"71","author":"WG Dixon","year":"2012","unstructured":"Dixon WG, Abrahamowicz M, Beauchamp ME, Ray DW, Bernatsky S, Suissa S, Sylvestre MP (2012) Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case\u2013control analysis. Ann Rheum Dis 71(7):1128\u20131133. doi: 10.1136\/annrheumdis-2011-200702","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3143_CR19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/art.21568","volume":"54","author":"F Wolfe","year":"2006","unstructured":"Wolfe F, Caplan L, Michaud K (2006) Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis and rheumatism 54(2):628\u2013634. doi: 10.1002\/art.21568","journal-title":"Arthritis and rheumatism"},{"issue":"8","key":"3143_CR20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard.62.8.722","volume":"62","author":"C Turesson","year":"2003","unstructured":"Turesson C, O\u2019Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2003) Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 62(8):722\u2013727","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3143_CR21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, Vassallo R, Gabriel SE, Matteson EL (2010) Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis and rheumatism 62(6):1583\u20131591. doi: 10.1002\/art.27405","journal-title":"Arthritis and rheumatism"},{"issue":"8","key":"3143_CR22","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/acr.21986","volume":"65","author":"C Nannini","year":"2013","unstructured":"Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, Vassallo R, Gabriel SE, Matteson EL, Bongartz T (2013) Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a population-based study. Arthritis Care Res (Hoboken) 65(8):1243\u20131250. doi: 10.1002\/acr.21986","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"3143_CR23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","volume":"59","author":"KG Saag","year":"2008","unstructured":"Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, Paulus HE, Mudano A, Pisu M, Elkins-Melton M, Outman R, Allison JJ, Suarez Almazor M, Bridges SL Jr, Chatham WW, Hochberg M, MacLean C, Mikuls T, Moreland LW, O\u2019Dell J, Turkiewicz AM, Furst DE (2008) American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis and rheumatism 59(6):762\u2013784. doi: 10.1002\/art.23721","journal-title":"Arthritis and rheumatism"},{"issue":"1","key":"3143_CR24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/art.11481","volume":"50","author":"ET Molenaar","year":"2004","unstructured":"Molenaar ET, Voskuyl AE, Dinant HJ, Bezemer PD, Boers M, Dijkmans BA (2004) Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis and rheumatism 50(1):36\u201342. doi: 10.1002\/art.11481","journal-title":"Arthritis and rheumatism"},{"issue":"5","key":"3143_CR25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/annrheumdis-2011-200395","volume":"71","author":"JS Smolen","year":"2012","unstructured":"Smolen JS, Avila JC, Aletaha D (2012) Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction. Ann Rheum Dis 71(5):687\u2013693. doi: 10.1136\/annrheumdis-2011-200395","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-3143-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-3143-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-3143-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T04:11:46Z","timestamp":1718251906000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-3143-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,17]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["3143"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-3143-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,17]]}}}